Home
Forums
New posts
What's new
New posts
Latest activity
Members
Registered members
Current visitors
Log in
What's new
New posts
Menu
Log in
Install the app
Install
Home
Forums
Public Area
Timebomb2000
EPIDEMIC/PANDEMIC DISEASE ARCHIVES
Boston University CREATES a new Covid strain that has an 80% kill rate — echoing dangerous experiments feared to have started pandemic
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Members who reacted to message #43
All
(9)
Like
(9)
Oct 20, 2022
Raggedyman
Res ipsa loquitur
·
Location:
'murKKa - FEMA region IV
Messages
28,054
Reaction score
62,724
Points
294
F
Oct 18, 2022
FireDance
TB Fanatic
·
Location:
Pollenville
Messages
20,346
Reaction score
14,425
Points
294
Oct 17, 2022
Dusty Lady
Veteran Member
·
70
·
Location:
Cold Country
Messages
1,573
Reaction score
1,301
Points
119
M
Oct 17, 2022
Masterchief117
I'm all about the doom
·
Location:
In the Matrix.
Messages
3,181
Reaction score
3,315
Points
144
N
Oct 17, 2022
nehimama
Has No Life - Lives on TB
Messages
12,729
Reaction score
118,876
Points
194
Oct 17, 2022
pauldingbabe
The Great Cat
·
51
·
Location:
georgia
Messages
11,325
Reaction score
26,577
Points
194
Oct 17, 2022
psychgirl
Has No Life - Lives on TB
Messages
19,436
Reaction score
55,047
Points
194
Oct 17, 2022
subnet
Boot
·
Location:
Commiefornia
Messages
9,500
Reaction score
16,927
Points
194
Oct 17, 2022
Mprepared
Veteran Member
·
Location:
Idaho
Messages
2,290
Reaction score
6,040
Points
119
Loading…
Home
Forums
Public Area
Timebomb2000
EPIDEMIC/PANDEMIC DISEASE ARCHIVES
Boston University CREATES a new Covid strain that has an 80% kill rate — echoing dangerous experiments feared to have started pandemic
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top